Inhibitory effects of cationic hybrid liposomes on the growth of human renal cell carcinoma

Anticancer Research

Volumn 30, Issue 2, 2010, Pages 327-337

  Umebayashi, Masayo ^a   Makizono, Taku ^a   Ichihara, Hideaki ^a   Matsumoto, Yoko ^a   Ueoka, Ryuichi ^a  

^a SOJO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Cationic hybrid liposome; Chemotherapy; Renal cell carcinoma

Indexed keywords

CASPASE; CATIONIC HYBRID LIPOSOME; CHEMICAL COMPOUND; DIMYRISTOYLPHOSPHATIDYLCHOLINE; LIPOSOME; O,O' DITETRADECANOYL N (ALPHA TRIMETHYLAMMONIOACETYL) DIETHANOLAMINE CHLORIDE; POLIDOCANOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CELL FUSION; CELL MEMBRANE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GROWTH INHIBITION; HEMOLYSIS; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; DIMYRISTOYLPHOSPHATIDYLCHOLINE; FEMALE; FLOW CYTOMETRY; HEMOLYSIS; HUMANS; IN SITU NICK-END LABELING; KIDNEY NEOPLASMS; LIPOSOMES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, INBRED BALB C; MICE, NUDE;

EID: 77950543539     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Brendan D and Curti MD: Renal cell carcinoma. J Am Med Ass 292: 97-100, 2004.
2. Rabinovitch RA, Zelefsky MJ, Gaynor JJ and Fuks Z: Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy. J Clin Oncol 12: 206-212, 1994.
3. Motzer RJ and Russo P: Systemic therapy for renal cell carcinoma. J Urol 163: 408-417, 2000.
4. Robert J, Motzer MD, Neil H, Bander MD, David M and Nanus MD: Renal cell carcinoma. N Engl J Med 335: 865-875, 1996.
5. Tani K, Azuma M, Nakazaki Y, Oyaizu N, Hase H, Ohata J, Takahashi K, Oiwamonna M, Hanazawa K, Wakumoto Y, Kawai K, Noguchi M, Soda Y, Kunisaki R, Watari K, Takahashi S, Machida U, Satoh N, Tojo A, Maekawa T, Eriguchi M, Tomikawa S, Tahara H, Inoue Y, Yoshikawa H, Yamada Y, Iwamoto A, Hamada H, Yamashita N, Okumura K, Kakizoe T, Akaza H, Fujime M, Clift S, Ando D, Mulligan R and Asano S: Phase I study of autologous tumor vaccines transduced with the GM-CSF gene in four patients with stage IV renal cell cancer in Japan: clinical and immunological findings. Mol Ther 10: 799-816, 2004.
6. Bangham AD, Sandish MM and Watkins JC: Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13: 238-252, 1965.
7. Gabizon A, Catane R, Uziely B, Kaufman B, Safra T, Cohen R, Martin F, Huang A and Barenholz Y: Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 54: 987-992, 1994.
8. Graybill JR, Craven PC, Taylor RL, Williams DM and Magee WE: Treatment of murine cryptococcosis with liposome-associated amphotericin B. J Infect Dis 145: 748-752, 1982.
9. Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM and Danielsen M: Lipofection : A highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 84: 7413-7417, 1987.
10. Yoshida J, Mizuno M and Wakabayashi T: Interferon-beta gene therapy for cancer: basic research to clinical application. Cancer Sci 95: 858-865, 2004.
11. Kikuchi A, Aoki Y, Sugaya S, Serikawa T, Takakuwa K, Tanaka K, Suzuki N and Kikuchi H: Development of novel cationic liposomes for efficient gene transfer into peritoneal disseminated tumor. Hum Gene Ther 10: 947-955, 1999.
12. Ueoka R, Moss RA, Swarup S, Matsumoto Y, Strauss G and Murakami Y: Extraordinary micellar enantioselectivity coupled to altered aggregate structure. J Am Chem Soc 107: 2185-2186, 1985.
13. Ueoka R, Matsumoto Y, Moss RA, Swarup S, Sugii A, Harada J, Kikuchi Y and Murakami Y: Membrane matrix for the hydrolysis of amino acid esters with marked enantioselectivity. J Am Chem Soc 110: 1588-1595, 1988.
14. Kitamura I, Kochi M, Matsumoto Y, Ueoka R, Kuratsu J and Ushio Y: Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study. Cancer Res 56: 3986-3992, 1996.
15. Matsumoto Y, Imamura C, Ito T, Taniguchi C and Ueoka R: Specific hybrid liposomes composed of phosphatidylcholine and polyoxyethylenealkyl ether with markedly enhanced inhibitory effect on the growth of tumor cells in vitro. Biol Pharm Bull 18: 1456-1458, 1995.
16. Matsumoto Y, Kato T, Iseki S, Suzuki H, Nakano K, Iwahara M and Ueoka R: Remarkably enhanced inhibitory effects of hybrid liposomes on the growth of specific tumor cells. Bioorg Med Chem Lett 9: 1937-1940, 1999.
17. Kanno A, Terada Y, Tsuzaki K, Matsumoto Y and Ueoka R: Therapeutic effects of hybrid liposomes on mice model of lung carcinoma. Drug Del Syst 14: 37-42, 1999.
18. Ueoka R, Matsumoto Y, Kanno A, Tsuzaki K and Ichihara H: Marked therapeutic effect of dimyristoylphosphatidylcholine liposomes on carcinoma mouse model in vivo. Biol Pharm Bull 23: 1262-1263, 2000.
19. Ichihara H, Nagami H, Kiyokawa T, Matsumoto Y and Ueoka R: Chemotherapy using hybrid liposomes along with induction of apoptosis. Anticancer Res 28: 1187-1196, 2008.
20. Matsumoto Y, Iwamoto Y, Matsushita T and Ueoka R: Novel mechanism of hybrid liposomes-induced apoptosis in human tumor cells. Int J Cancer 115: 377-382, 2005.
21. Komizu Y, Matsumoto Y and Ueoka R: Membrane targeted chemotherapy with hybrid liposomes for colon tumor cells leading to apoptosis. Bioorg Med Chem Lett 16: 6131-6134, 2006.
22. Kinouchi T, Kotake T, Mori Y and Abe T: Human renal cell carcinoma: establishment and characterization of a new cell line (OS-RC-2). In Vitro Cell Dev Biol 21: 195-199, 1985.
23. Casciola-Rosen L, Nicholson DW, Chong T, Rowan KR, Thornberry NA, Miller DK and Rosen A: Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J Exp Med 183: 1957-1964, 1996.
24. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG and Earnshaw WC: Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371: 346-347, 1994.
25. Oren Z and Shai Y: Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: structure-function study. Biochemistry 36: 1826-1835, 1997.
26. Subbalakshmi C, Nagaraj R and Sitaram N: Biological activities of C-terminal 15-residue synthetic fragment of melittin: design of an analog with improved antibacterial activity. FEBS Lett 448: 62-66, 1999
27. Asthana N, Yadav SP and Ghosh JK: Dissection of antibacterial and toxic activity of melittin: a leucine zipper motif plays a crucial role in determining its hemolytic activity but not antibacterial activity. J Biol Chem 279: 55042-55050, 2004.
28. Martin FJ and MacDonald RC: Lipid vesicle-cell interactions. I. Hemagglutination and hemolysis. J Cell Biol 70: 494-505, 1976.
29. Heng DY and Kollmannsberger C: Sunitinib. Recent Results Cancer Res 184: 71-82, 2010.
30. Imamura C, Kanno A, Mitsuoka C, Kitajima S, Inoue H, Iwahara M, Matsumoto Y and Ueoka R: Specific inhibitory effect of hybrid liposomes on the growth of hybridoma cells in vitro. Yakugaku Zasshi 116: 942-950, 1996. (In Japanese.)
31. Matsumoto Y, Kato T, Iseki S, Suzuki H, Nakano K and Ueoka R: Specific inhibitory effects of hybrid liposomes on the growth of various tumor cells. Yakugaku Zasshi 119: 280-287, 1999. (In Japanese.)
32. Komizu Y, Matsumoto Y and Ueoka R: Membrane-targeted chemotherapy with hybrid liposomes for colon tumor cells leading to apoptosis. Bioorg Med Chem Lett 16: 6131-6134, 2006.
33. Utsugi T, Schroit AJ, Connor J, Bucana CD and Fidler IJ: Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer Res 51: 3062-3066, 1991.
34. Schröder-Borm H, Bakalova R and Andrä J: The NK-lysin derived peptide NK-2 preferentially kills cancer cells with increased surface levels of negatively charged phosphatidylserine. FEBS Lett 579: 6128-6134, 2005.
35. Allen TM, Hansen CJ, Martin F, Redemann C and Yan YA: Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochem Biophys Acta 1066: 29-36, 1991.